Innophos (NASDAQ:IPHS) will be announcing its earnings results before the market opens on Tuesday, August 6th. Analysts expect the company to announce earnings of $0.34 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Innophos (NASDAQ:IPHS) last announced its quarterly earnings data on Tuesday, April 30th. The specialty chemicals company reported $0.57 EPS for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.14. The firm had revenue of $191.41 million for the quarter, compared to analyst estimates of $199.90 million. Innophos had a return on equity of 13.09% and a net margin of 4.30%. The business’s quarterly revenue was down 6.8% compared to the same quarter last year. During the same period last year, the company earned $0.61 EPS. On average, analysts expect Innophos to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
IPHS traded down $0.07 during mid-day trading on Tuesday, reaching $27.27. The stock had a trading volume of 1,568 shares, compared to its average volume of 59,638. The company has a market cap of $543.09 million, a PE ratio of 11.95 and a beta of 1.41. The company has a quick ratio of 1.49, a current ratio of 3.14 and a debt-to-equity ratio of 0.95. The stock has a fifty day moving average price of $27.92. Innophos has a 52 week low of $22.57 and a 52 week high of $49.42.
IPHS has been the topic of several recent research reports. BidaskClub upgraded Zai Lab from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 28th. TheStreet lowered ZovioInc . from a “c-” rating to a “d” rating in a research report on Thursday, May 23rd. Finally, Zacks Investment Research lowered Hallmark Financial Services from a “buy” rating to a “hold” rating in a research report on Thursday, July 25th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $31.00.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Further Reading: Arbitrage
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.